CIK 0000939767 · Large accelerated filer
EXELIXIS, INC.
Sign in to watch- Ticker
- EXEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jan 1
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043257395
- Phone
- 6508377000
- Business address
- 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
- Former names
- EXELIXIS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-14 | Freire Maria C Director | Option exercise · Option (right to buy) | −15,874 | 0 | ||
| 2025-02-14 | Freire Maria C Director | Option exercise · Option (right to buy) | −28,240 | 0 | ||
| 2025-02-14 | Eckhardt Sue Gail Director | Option exercise 10b5-1 | +7,712 | $23.24 | $179K | 41,974 |
| 2025-02-14 | Eckhardt Sue Gail Director | Sale 10b5-1 | −7,712 | $35.01 | $270K | 34,262 |
| 2025-02-14 | Eckhardt Sue Gail Director | Sale 10b5-1 | −3,856 | $35.04 | $135K | 30,406 |
| 2025-02-14 | Eckhardt Sue Gail Director | Option exercise · Option (right to buy) 10b5-1 | −7,712 | 23,136 | ||
| 2025-01-16 | MORRISSEY MICHAEL President and CEO | Grant or award | +473,226 | 1,210,180 | ||
| 2025-01-16 | MORRISSEY MICHAEL President and CEO | Shares withheld for taxes | −120,244 | $37.27 | $4.5M | 1,089,936 |
| 2025-01-16 | Senner Christopher J. EVP and CFO | Grant or award | +132,973 | 837,147 | ||
| 2025-01-16 | Senner Christopher J. EVP and CFO | Shares withheld for taxes | −35,949 | $37.27 | $1.3M | 801,198 |
| 2025-01-16 | Hessekiel Jeffrey EVP & General Counsel | Grant or award | +118,780 | 589,839 | ||
| 2025-01-16 | Hessekiel Jeffrey EVP & General Counsel | Shares withheld for taxes | −26,289 | $37.27 | $980K | 563,550 |
| 2025-01-16 | Aftab Dana CSO/EVP Disc & Trans Research | Grant or award | +104,106 | 590,213 | ||
| 2025-01-16 | Aftab Dana CSO/EVP Disc & Trans Research | Shares withheld for taxes | −22,570 | $37.27 | $841K | 567,643 |
| 2025-01-16 | Haley Patrick J. EVP, Commercial | Grant or award | +123,750 | 402,415 | ||
| 2025-01-16 | Haley Patrick J. EVP, Commercial | Shares withheld for taxes | −27,563 | $37.27 | $1.0M | 374,852 |
| 2024-12-20 | MORRISSEY MICHAEL President and CEO | Gift | −179,788 | 736,954 | ||
| 2024-12-20 | MORRISSEY MICHAEL President and CEO | Gift | +179,788 | 1,587,000 | ||
| 2024-11-29 | Hessekiel Jeffrey EVP & General Counsel | Sale | −60,000 | $36.67 | $2.2M | 486,059 |
| 2024-11-29 | Hessekiel Jeffrey EVP & General Counsel | Gift | −15,000 | 471,059 |
Page 11 of 20 · 381 trades